These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5807483)

  • 61. [Microbiological substantiation of the use of erycycline in the therapy of chronic pyoderma].
    Bukharovich AM
    Antibiotiki; 1982 Mar; 27(3):199-202. PubMed ID: 7092196
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Scabies and pyodermas--diagnosis and treatment.
    Hay RJ
    Dermatol Ther; 2009; 22(6):466-74. PubMed ID: 19889132
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Clinico-experimental substantiation of the complex treatment of patients with pyoderma using dimocifone].
    Bukharovich AM; Goloshchapov NM
    Vestn Dermatol Venerol; 1984 Sep; (9):14-9. PubMed ID: 6524043
    [No Abstract]   [Full Text] [Related]  

  • 64. [Antibiotic resistance of staphylococci isolated from patients with chronic pyoderma].
    Fedorovskaia RF; Khapilova VI; Bednova VN; Danilova TN
    Vestn Dermatol Venerol; 1975 Oct; (10):62-5. PubMed ID: 1227120
    [No Abstract]   [Full Text] [Related]  

  • 65. [Value of quantitative bacteriological examination of sputum in the evaluation of the effectiveness of chemotherapy of bacterial respiratory tract infections. II. Clinical studies].
    Nikodemowicz E; Owsiński J; Przybyłkiewicz Z; Kasprowicz A; Maternowska W; Kamińska M; Walaszek K; Prus F
    Pneumonol Pol; 1980 Aug; 48(8):545-22. PubMed ID: 6968434
    [No Abstract]   [Full Text] [Related]  

  • 66. Comparison of antibiotic therapy in presumptive bacterial conjunctivitis.
    Jarudi N; Golden B; Hoyme J; Tyson MD; Harter JG
    Am J Ophthalmol; 1975 May; 79(5):790-4. PubMed ID: 167583
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Antibiotic therapy of staphylococcal pyodermatitis].
    Shaposhnikov OK; Shchedrin VI
    Voen Med Zh; 1981 Sep; (9):35-7. PubMed ID: 7303528
    [No Abstract]   [Full Text] [Related]  

  • 68. [Rimactan. Experimental studies and clinical experience].
    Meyer-Rohn J; Lautenschlager HJ
    Munch Med Wochenschr; 1969 Aug; 111(33):1646-50. PubMed ID: 5395306
    [No Abstract]   [Full Text] [Related]  

  • 69. ["Bacteriostatic test"- a method of the study of microbial sensitivity to antibiotics].
    Rachinskiĭ SV; Zakhidova EKh
    Lab Delo; 1974; (12):732-5. PubMed ID: 4140963
    [No Abstract]   [Full Text] [Related]  

  • 70. [Clinical experience in the use of parenteral oxacillin-ampicillin (Broadcillin "Banyu")].
    Yabuuchi M; Nakamura O
    Jpn J Antibiot; 1970 Apr; 23(2):123-6. PubMed ID: 5311038
    [No Abstract]   [Full Text] [Related]  

  • 71. [On the resistance to antibiotics and bacteriophages of pathogenic staphylococci isolated from hospital environments and from collectivities of young children].
    Gherman DN; Zalman MW
    Arch Roum Pathol Exp Microbiol; 1970 Dec; 29(4):629-35. PubMed ID: 4255814
    [No Abstract]   [Full Text] [Related]  

  • 72. [Leukomycin in the treatment of various infectious disorders of the skin and soft parts].
    Hernández B; Bravo PA; Fernández A; Cruz M; Zárraga J; Añorve I
    Prensa Med Mex; 1970; 35(11):479-83. PubMed ID: 4252929
    [No Abstract]   [Full Text] [Related]  

  • 73. [Efficacy of semisynthetic antibiotics in the treatment of pustular diseases of the skin].
    Shchedrin VI; Baranov BA
    Voen Med Zh; 1984 Nov; (11):57-8. PubMed ID: 6528497
    [No Abstract]   [Full Text] [Related]  

  • 74. [On the treatment of superficial staphylococcal diseases in childhood with Fucidin-gel].
    Staemmler HG; Rodeck H; Linzenmeier G
    Dtsch Med Wochenschr; 1968 Sep; 93(36):1714-6. PubMed ID: 5668265
    [No Abstract]   [Full Text] [Related]  

  • 75. [Lung abscesses, their etiology and drug resistance].
    Cesarz-Fronczyk M; Porucznik J; Rymsza J
    Wiad Lek; 1988 Feb; 41(3):153-6. PubMed ID: 3414109
    [No Abstract]   [Full Text] [Related]  

  • 76. In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007-2009 study.
    Karlowsky JA; Adam HJ; Poutanen SM; Hoban DJ; Zhanel GG;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):342-7. PubMed ID: 21353963
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Doxycycline-a broad spectrum antibiotic of the tetracycline series].
    Pulverer G
    Med Klin; 1969 May; 64(22):1033-7. PubMed ID: 4389766
    [No Abstract]   [Full Text] [Related]  

  • 78. [STAPHYLOCOCCAL RESISTANCE TO ANTIBIOTICS AND CHARACTERISTICS OF THE COURSE OF SUPPURATIVE INFECTIONS IN CHILDREN].
    KHRISTICH AD
    Khirurgiia (Mosk); 1964 Feb; 40():24-9. PubMed ID: 14170175
    [No Abstract]   [Full Text] [Related]  

  • 79. Early recognition and treatment of staphylococcal and streptococcal toxic shock.
    Nelson C
    J Pediatr Adolesc Gynecol; 2004 Aug; 17(4):289-92. PubMed ID: 15288032
    [No Abstract]   [Full Text] [Related]  

  • 80. In vitro and in vivo evaluation of enduracidin, a new peptide antibiotic substance.
    Goto S; Kuwahara S; Okubo N; Zenyoji H
    J Antibiot (Tokyo); 1968 Feb; 21(2):119-25. PubMed ID: 4299887
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.